167 related articles for article (PubMed ID: 29264182)
1. Stents for malignant ureteral obstruction.
Pavlovic K; Lange D; Chew BH
Asian J Urol; 2016 Jul; 3(3):142-149. PubMed ID: 29264182
[TBL] [Abstract][Full Text] [Related]
2. Malignant Ureteral Obstruction: Functional Duration of Metallic versus Polymeric Ureteral Stents.
Chow PM; Chiang IN; Chen CY; Huang KH; Hsu JS; Wang SM; Lee YJ; Yu HJ; Pu YS; Huang CY
PLoS One; 2015; 10(8):e0135566. PubMed ID: 26267140
[TBL] [Abstract][Full Text] [Related]
3. Management of single double-J stent failure in malignant ureteral obstruction: tandem ureteral stenting with less frequent stent exchange.
Akıncı D; Ünal E; Çiftçi TT; Özkan OŞ; Akhan O
Diagn Interv Radiol; 2023 Mar; 29(2):312-317. PubMed ID: 36987982
[TBL] [Abstract][Full Text] [Related]
4. Ureteric stents vs percutaneous nephrostomy for initial urinary drainage in children with obstructive anuria and acute renal failure due to ureteric calculi: a prospective, randomised study.
ElSheemy MS; Shouman AM; Shoukry AI; ElShenoufy A; Aboulela W; Daw K; Hussein AA; Morsi HA; Badawy H
BJU Int; 2015 Mar; 115(3):473-9. PubMed ID: 24698195
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Outcomes of Double-Layered Polytetrafluoroethylene Membrane-Covered Self-Expandable Segmental Metallic Stents (Uventa) in Patients with Chronic Ureteral Obstructions: Is It Really Safe?
Kim M; Hong B; Park HK
J Endourol; 2016 Dec; 30(12):1339-1346. PubMed ID: 27736158
[TBL] [Abstract][Full Text] [Related]
6. Multicenter experience of the newly designed covered metallic ureteral stent for malignant ureteral occlusion: comparison with double J stent insertion.
Chung HH; Kim MD; Won JY; Won JH; Cho SB; Seo TS; Park SW; Kang BC
Cardiovasc Intervent Radiol; 2014 Apr; 37(2):463-70. PubMed ID: 23925919
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated with Ureteral Stent Failure in Patients with Malignant Ureteral Obstruction.
Pickersgill NA; Wahba BM; Vetter JM; Cope SJ; Barashi NS; Henning GM; Du K; Figenshau RS; Desai AC; Venkatesh R
J Endourol; 2022 Jun; 36(6):814-818. PubMed ID: 35018790
[No Abstract] [Full Text] [Related]
8. Ureteric stent versus percutaneous nephrostomy for acute ureteral obstruction - clinical outcome and quality of life: a bi-center prospective study.
Shoshany O; Erlich T; Golan S; Kleinmann N; Baniel J; Rosenzweig B; Eisner A; Mor Y; Ramon J; Winkler H; Lifshitz D
BMC Urol; 2019 Aug; 19(1):79. PubMed ID: 31455309
[TBL] [Abstract][Full Text] [Related]
9. Palliative care of malignant ureteral obstruction with polytetrafluoroethylene membrane-covered self-expandable metallic stents: initial experience.
Kim JH; Song K; Jo MK; Park JW
Korean J Urol; 2012 Sep; 53(9):625-31. PubMed ID: 23061000
[TBL] [Abstract][Full Text] [Related]
10. Stenting for malignant ureteral obstruction: Tandem, metal or metal-mesh stents.
Elsamra SE; Leavitt DA; Motato HA; Friedlander JI; Siev M; Keheila M; Hoenig DM; Smith AD; Okeke Z
Int J Urol; 2015 Jul; 22(7):629-36. PubMed ID: 25950837
[TBL] [Abstract][Full Text] [Related]
11. Wire-reinforced ureteral stents to rescue from nephrostomy tube in extrinsic ureteral obstruction.
Dauw CA; Faerber GJ; Hollingsworth JM; Wolf JS
Can J Urol; 2015 Jun; 22(3):7806-10. PubMed ID: 26068630
[TBL] [Abstract][Full Text] [Related]
12. Tandem ureteral stents drainage lowers renal pelvis pressure in malignant ureteral obstruction: Experimental and computational models.
Haifler M; Kleinmann N; Weiss D
J Biomech; 2021 Mar; 117():110237. PubMed ID: 33486265
[TBL] [Abstract][Full Text] [Related]
13. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
Matsuura H; Arase S; Hori Y
Int J Clin Oncol; 2019 Mar; 24(3):306-312. PubMed ID: 30298199
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Double-J Metallic Mesh Ureteral Stents for Malignant Ureteral Obstruction: A Retrospective Study.
Hori T; Makino T; Kawahara T; Urata S; Miyagi T
In Vivo; 2023; 37(2):806-810. PubMed ID: 36881102
[TBL] [Abstract][Full Text] [Related]
15. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
[TBL] [Abstract][Full Text] [Related]
16. Risk factors in the prediction of long-term patency of Resonance metallic ureteric stent in malignant ureteric obstruction.
Ho BSH; Chiu PKF; Lam W; Wong JHF; Wong CKW; Lai TCT; Tsang CF; Ng ATL; Chan CK; Ma WK; Ng CF; Tsu JHL
BJUI Compass; 2020 May; 1(2):74-81. PubMed ID: 35474710
[TBL] [Abstract][Full Text] [Related]
17. Predicting the success of retrograde stenting for managing ureteral obstruction.
Yossepowitch O; Lifshitz DA; Dekel Y; Gross M; Keidar DM; Neuman M; Livne PM; Baniel J
J Urol; 2001 Nov; 166(5):1746-9. PubMed ID: 11586215
[TBL] [Abstract][Full Text] [Related]
18. [Management of malignant ureteral obstruction.].
Jaunarena JH; Cristallo C; González MS; Daels FP; De la Rosette J; Laguna MP
Arch Esp Urol; 2016 Oct; 69(8):507-517. PubMed ID: 27725327
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a covered metallic ureteral stent and a double-J stent for malignant ureteral obstruction in advanced gastric cancer.
Kim ET; Yang WJ; Shin JH; Cho SJ; Song SY; Song MG; Kang D
Clin Radiol; 2021 Jul; 76(7):519-525. PubMed ID: 33736879
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.
Ohtaka M; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Makiyama K; Miyoshi Y; Yumura Y; Yao M; Uemura H
BMC Urol; 2018 May; 18(1):35. PubMed ID: 29739370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
